Business Standard

Sunday, January 05, 2025 | 04:01 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Covid-19 antigen testing: India next stop for Siemens Healthineers

The investment is part of Siemens Healthineers' strategy 2025, in which India plays an important role as a growth market for the firm.

Siemens campus. Photo: Wikipedia
Premium

Siemens sells two types of antibody tests in India. One tests antibodies (both IgG and IgM) and another the level of IgG antibodies in a person’s blood

Sohini Das Mumbai
Siemens Healthineers, a Frankfurt-based medical-technology firm, will soon bring to India its Covid-19 antigen test, which it launched in Europe last week.

The firm is expanding its facility in Vadodara to make molecular assays there. It will manufacture RT-PCR, antibody and antigen test kits at the facility. Siemens imports these tests from plants in the US and Europe.

Given the growing demand for Covid-19 diagnostic tests, the firm has decided to manufacture here. “It makes entry-level blood analysers and reagents and is expanding the facility to make molecular assay tests,” said Vivek Kanade, executive vice-president (Zone India), Siemens Healthineers.

This could play a

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in